Xeris Biopharma Holdings (XERS) Total Debt (2020 - 2026)
Xeris Biopharma Holdings (XERS) posted Total Debt of $252.59 million for Q2 2026, up 15.5% from $218.63 million a year earlier and up 14.2% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Total Debt (2020 - 2026) Analysis & Trends
At the end of FY2025, Xeris Biopharma Holdings' Total Debt came in at $220.34 million, down 5.1% from FY2024.
- In prior years, Xeris Biopharma Holdings' Total Debt was $232.11 million in FY2024 (+21.6%) and $190.93 million in FY2023.
- The Q2 2026 figure stands as the highest quarterly Total Debt in data going back to Q4 2023.
- On a year-over-year basis, Total Debt increased in two of the last four quarters, with growth averaging 7.1%.
- According to Business Quant data, Total Debt for the three prior quarters was $221.22 million (Q1 2026), $220.34 million (Q4 2025) and $219.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Xeris Biopharma Holdings | 1.86 Bn | 1.43 Bn | 79.59 Mn | 252.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 252.59 Mn |
| Mar 31, 2026 | 221.22 Mn |
| Dec 31, 2025 | 220.34 Mn |
| Sep 30, 2025 | 219.47 Mn |
| Jun 30, 2025 | 218.63 Mn |
| Mar 31, 2025 | 229.76 Mn |
| Dec 31, 2024 | 232.11 Mn |
| Sep 30, 2024 | 15.06 Mn |
| Jun 30, 2024 | 230.48 Mn |
| Mar 31, 2024 | 229.67 Mn |
| Dec 31, 2023 | 190.93 Mn |
| Sep 30, 2023 | 190.42 Mn |
| Jun 30, 2023 | 188.18 Mn |
| Mar 31, 2023 | 187.62 Mn |
| Dec 31, 2022 | 187.08 Mn |
| Sep 30, 2022 | 138.51 Mn |
| Jun 30, 2022 | 138.07 Mn |
| Mar 31, 2022 | 137.64 Mn |
| Dec 31, 2021 | 88.07 Mn |
| Sep 30, 2021 | 87.71 Mn |
API Access
Xeris Biopharma Holdings Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();